ART 2020 - Advanced Retinal Therapy

Obviously, a conference on “advanced” therapy will take full benefit of the dynamic digital times!
In general, the field of retina has been greatly blessed with innovation during recent years. Break-throughs in diagnostic imaging as well as in technologies such as artificial intelligence (AI) and gene therapy continue finding most constructive grounds in ophthalmology.

For this year’s conference, we will, for a good reason, focus on current perspectives in AI and our experiences with its potential to support clinical diagnosis, not only in ophthalmic conditions, but also in ocular manifestation of systemic diseases. The retina, a window to the body, has become a playground for clinical scientists and computer specialists who are developing AI algorithms for diagnosis of ocular, but even more so the leading systemic diseases of industrialized countries such as diabetes, cardiovascular disease and neurodegeneration.

This is clearly introducing a large paradigm shift in medicine and in the society, which will be the Keynote Lecture at ART 2020 given by the author Marlene Streeruwitz.

Despite the discovery of novel grounds, solid expertise and experience is the base of quality in medicine. Known experts in the field will therefore share their knowledge with their colleagues for training and learning, by the way, a common motif in AI as well.

The good will and flexibility of our speakers and audience will enable the community to move through harsh times safely while maintaining and further advancing scientific curiosity and medical responsibility.

Looking forward to see and listen to you in personalized virtuality,

Univ.-Prof. Dr. Ursula Schmidt-Erfurth
Professor and Chair

Medical University Vienna
Department of Ophthalmology and Optometry

Robert Miller Professor
Feinberg School of Medicine
Northwestern University Chicago

Austrian Academy of Sciences
Full member